Recombinant Human RNF183 Protein，GST

RNF183 is an E3 ubiquitin ligase that plays a crucial role in the regulation of protein degradation and various cellular processes, including apoptosis, cell cycle progression, and immune responses. Its involvement in these pathways has made it a significant focus of research, particularly in the context of cancer and autoimmune diseases. Recent studies have indicated that RNF183 may be implicated in the modulation of signaling pathways associated with tumorigenesis, suggesting that it could serve as a potential biomarker for cancer progression or a target for therapeutic intervention. Additionally, the ability of RNF183 to interact with various substrate proteins highlights its importance in maintaining cellular homeostasis. As a result, the characterization and functional analysis of recombinant RNF183 protein have become essential in understanding its biological roles and mechanisms of action. Researchers are actively investigating its structure, substrate specificity, and regulatory mechanisms to elucidate how RNF183 contributes to disease pathology and to explore its potential applications in targeted therapies. The ongoing efforts to express and purify recombinant RNF183 protein will facilitate the development of assays to study its activity and interactions, paving the way for future breakthroughs in the field of molecular biology and therapeutic development.